O
8.79
0.18 (2.09%)
| 前收盘价格 | 8.61 |
| 收盘价格 | 8.95 |
| 成交量 | 909,424 |
| 平均成交量 (3个月) | 523,462 |
| 市值 | 162,204,512 |
| 预期市盈率 (P/E Forward) | 21.51 |
| 价格/销量 (P/S) | 1.66 |
| 股市价格/股市净资产 (P/B) | 1.32 |
| 52周波幅 | |
| 利润日期 | 12 May 2025 - 16 May 2025 |
| 营业毛利率 | -21.83% |
| 营业利益率 (TTM) | 11.24% |
| 稀释每股收益 (EPS TTM) | -1.10 |
| 季度收入增长率 (YOY) | 13.90% |
| 总债务/股东权益 (D/E MRQ) | 28.37% |
| 流动比率 (MRQ) | 2.89 |
| 营业现金流 (OCF TTM) | 4.89 M |
| 杠杆自由现金流 (LFCF TTM) | 9.40 M |
| 资产报酬率 (ROA TTM) | -2.19% |
| 股东权益报酬率 (ROE TTM) | -16.51% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 看跌 | 混合的 |
| Health Information Services (全球的) | 看跌 | 混合的 | |
| 股票 | OptimizeRx Corporation | 看涨 | 看跌 |
AIStockmoo 评分
0.3
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | 0.25 |
|
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Core |
| 内部持股比例 | 6.41% |
| 机构持股比例 | 65.38% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 14.00 (JMP Securities, 59.27%) | 购买 |
| 中 | 13.25 (50.74%) | |
| 低 | 12.50 (Stifel, 42.21%) | 购买 |
| 平均值 | 13.25 (50.74%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 0.000 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JMP Securities | 13 May 2025 | 14.00 (59.27%) | 购买 | 0.000 |
| Stifel | 13 May 2025 | 12.50 (42.21%) | 购买 | 0.000 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合